Clinical Trial Update: Stellarex Vascular E-Registry

View source ↗

Summary

The Stellarex Vascular E-Registry trial sponsored by Spectranetics has completed, evaluating outcomes in peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Stellarex Paclitaxel-Coated Balloon (paclitaxel-coated balloon catheter)

Snippet

Sponsor: Spectranetics Corporation | Conditions: Peripheral Arterial Disease | Status: COMPLETED